Your browser doesn't support javascript.
Pharmacotherapics Advice in Guidelines for COVID-19.
Chen, Zhang-Ren; Zhou, Ying; Liu, Jin; Peng, Hong-Wei; Zhou, Jian; Zhong, Hai-Li; Liu, Li-Li; Lai, Ming-Fang; Wei, Xiao-Hua; Wen, Jin-Hua.
  • Chen ZR; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhou Y; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu J; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Peng HW; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhou J; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Zhong HL; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu LL; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Lai MF; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wei XH; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wen JH; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Front Pharmacol ; 11: 950, 2020.
Article in English | MEDLINE | ID: covidwho-646238
ABSTRACT
Since December 2019 to May 2020, coronavirus disease 2019 (COVID-19) has infected over 6 million people worldwide. Due to its sudden and rapid outbreak, effective treatment for COVID-19 is scarce. Based on national clinical trials of novel treatments, China, Italy, Germany, and other countries and organizations have published multiple guidelines for COVID-19 and advised many medicines, such as chloroquine and tocilizumab. In this paper, we summarize the pharmacotherapy for COVID-19 according to those guidelines, highlight updates of the pharmacotherapy guidelines, and review the efficacy and safety of the indicated anti-COVID-19 drugs.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.00950

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Front Pharmacol Year: 2020 Document Type: Article Affiliation country: Fphar.2020.00950